# A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors

> **NCT02133625** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 14 (actual)

## Conditions studied

- Advanced Solid Tumor
- Metastatic Solid Tumor

## Interventions

- **DRUG:** carboplatin
- **DRUG:** pioglitazone

## Key facts

- **NCT ID:** NCT02133625
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2016-03
- **Final completion:** 2026-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02133625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02133625, "A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02133625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*